Hong Kong stocks surged | Hutchison Pharma (00013.HK) rises more than 5% in the morning and announces that the combination therapy of Votrient and Tareg has been approved by the National Medical Products Administration.

According to the Securities Times APP, China Resources Pharmaceutical (00013.HK) rose more than 5% in the morning, up 4.88% by the time of publication, to 24.7 Hong Kong dollars, with a turnover of 1.88 billion Hong Kong dollars.